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ABSTRACT
New hair follicles (HFs) do not form in adult mammalian skin unless
epidermal Wnt signalling is activated genetically or within large
wounds. To understand the postnatal loss of hair forming ability we
monitored HF formation at small circular (2 mm) wound sites. At P2,
new HFs formed in back skin, but HF formation was markedly
decreased by P21. Neonatal tail also formed wound-associated HFs,
albeit in smaller numbers. Postnatal loss of HF neogenesis did not
correlate with wound closure rate but with a reduction in Lrig1-positive
papillary fibroblasts in wounds. Comparative gene expression
profiling of back and tail dermis at P1 and dorsal fibroblasts at P2
and P50 showed a correlation between loss of HF formation and
decreased expression of genes associated with proliferation andWnt/
β-catenin activity. Between P2 and P50, fibroblast density declined
throughout the dermis and clones of fibroblasts became more
dispersed. This correlated with a decline in fibroblasts expressing a
TOPGFP reporter of Wnt activation. Surprisingly, between P2 and
P50 therewas no difference in fibroblast proliferation at thewound site
but Wnt signalling was highly upregulated in healing dermis of P21
compared with P2 mice. Postnatal β-catenin ablation in fibroblasts
promoted HF regeneration in neonatal and adult mouse wounds,
whereas β-catenin activation reduced HF regeneration in neonatal
wounds. Our data support a model whereby postnatal loss of hair
forming ability in wounds reflects elevated dermal Wnt/β-catenin
activation in the wound bed, increasing the abundance of fibroblasts
that are unable to induce HF formation.
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INTRODUCTION
Mammalian skin comprises two layers: the epidermis and dermis.
The epidermis is made up of the interfollicular epidermis (IFE), the
hair follicles (HFs), sweat glands and sebaceous glands and is
maintained through the activity of distinct stem cell subpopulations
(Watt, 2014). The underlying connective tissue, the dermis, is
composed of distinct layers. The papillary (upper) dermis is the
closest dermal layer to the epidermis and contains thin collagen fibres
and a high density of fibroblasts. Below that lies the reticular (or
lower) dermis, and beneath that lies the dermal white adipocyte
(DWAT) layer, also known as the hypodermis (Driskell et al., 2014;
Sorrell and Caplan, 2004). In addition, there are condensations of
fibroblasts, called the dermal papilla (DP), at the base of the HFs,
fibroblasts that ensheath the HF [dermal sheath (DS) cells] and
smooth muscle cells in the arrector pili muscle (APM) attached to the
HF (Driskell et al., 2011a; Sennett and Rendl, 2012). The epidermis
and dermis form through highly coordinated epithelial-mesenchymal
interactions during development (Driskell et al., 2011a; Fuchs and
Horsley, 2008; Millar, 2002; Yang and Cotsarelis, 2010).
Skin fibroblasts from different anatomic sites have distinct and
characteristic gene expression patterns (Rinn et al., 2006; Rinn et al.,
2008). The differentially expressed genes are not only involved in
defining cell positional identity, but are also associated with
extracellular matrix (ECM) synthesis, lipid metabolism,
proliferation, cell migration and fate determination (Chang et al.,
2002). Positional differences in wound healing and regeneration
ability have been reported, such that oral mucosa wounds heal faster
with minimal scaring compared with cutaneous wounds (Chen
et al., 2010).
At embryonic day (E) 12.5 of mouse development, dermal
fibroblasts in back skin are capable of forming all the postnatal
dermal compartments (Driskell et al., 2013). However, at E16.5
lineage restriction occurs, such that fibroblasts that are expressing
Lrig1, Blimp1 (also known as Prdm1) or CD26 (also known as
Dpp4) at that time point give rise to papillary dermis, including
APM, DS and DP, while Dlk1-expressing fibroblasts give rise to the
reticular dermis and DWAT (Driskell et al., 2013). The papillary
lineage is required for new HF formation in skin reconstitution
assays, while the lower lineage gives rise to the fibroblasts that
mediate the initial phase of wound repair.
HF formation is normally restricted to embryonic development
(Schmidt-Ullrich and Paus, 2005). However, new HFs can be
induced in a range of adult mammals, including human, in the
context of wound repair (Breedis, 1954; Kligman, 1959). In adult
mice, new HFs form in the centre of very large (1 cm2) wounds as a
result of epidermal Wnt signalling (Gay et al., 2013; Ito et al., 2007;
Myung et al., 2013). Genetic activation of adult epidermal Wnt
signalling via β-catenin can induce ectopic HF formation in the
absence of wounding (Lo Celso et al., 2004; Silva-Vargas et al.,
2005) and this correlates with expansion of the papillary dermal
lineage (Driskell et al., 2013). Although new HFs do not normally
form in small (≤8 mm) circular full-thickness wounds in adult
mouse back skin, they can be induced if the number of papillary
fibroblasts is expanded in response to epidermal Wnt signalling
prior to wounding (Driskell et al., 2013).
Previous studies relating newHF formation to wound healing and
the role of different fibroblast subpopulations led us to investigate
why the ability to form new HFs is lost in postnatal life. WeReceived 12 October 2015; Accepted 1 June 2016
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measured the time in postnatal life when HF formation no longer
occurs in wounds and characterised the associated dermal changes.
Our observations lead to the conclusion that loss of hair forming
ability in adult wounds reflects increased recruitment of lower
lineage fibroblasts at the expense of papillary fibroblasts, and is
promoted by Wnt/β-catenin signalling in the wound dermis.
RESULTS
HF formation in wounds decreases with age and is location
dependent
To explore HF regeneration capacity, we made 2 mm full-thickness
circular wounds onmouse back and tail skin of different ages. Seven
days post wounding (PW7), new HFs had formed in the wound bed
of P2 back skin, with an average of five new HFs per wound bed
section (Fig. 1A,B). When P2 skin was wounded, all HF
developmental stages (Müller-Röver et al., 2001) were present at
PW7 (Fig. 1C), indicating that new HF formation was not a
synchronised process. The more developed HFs (stages 4-6) tended
to be at the wound edges, whereas placodes (stage 1) and stage 2-3
HFs were most abundant in the wound bed centre. The number of
new HFs per wound did not change between PW7 and PW14 (data
not shown), pointing to a limited, time-dependent window for HF
regeneration during wound healing. New HF formation strongly
declined with age, and after P21 only 0.8 new HFs per wound bed
section formed. The decline was not correlated with the hair cycle
(HC), since it occurred during the growth (anagen) phase of HF
morphogenesis (P6, P10), the first postnatal telogen (resting phase;
P21) and the second HC (P28-P50) (Fig. 1A,B).
P2 tails were too small to wound. However, when P10 tail was
wounded new HFs were detected in the wounds, albeit fewer
Fig. 1. Wound-induced new HF formation in neonatal back and tail skin. (A) Histological analysis of 2 mm wounds performed in PDGFRaH2BeGFP mice
postnatally by immunostaining for GFP (green) and Itga6 (red). Arrowheads indicate HFs within the wound bed and white lines demarcate the wound edges.
(B) New HF quantitation per wound bed section at PW7. n=4 (P2, P21) or n=3 (other time points) biological replicates. (C) Analysis of different HFmorphogenesis
stages during HF formation in P2 wounds at PW7. Wound beds were immunostained for GFP (green) and Itga6 (red) or Lef1 (green) alone. (D) Wound-induced
new HF formation in tail wounds. Tail wound beds were stained for Krt17 (green) and Itga6 (red) and quantified (see Table S1). Arrowhead indicates new HF.
(E-H) Light micrographs and quantification of PW7 wound area in back (E,F) and tail (G,H) skin wounds made at the ages shown. (I) Wound area over time in
neonatal and adult wounds as a surrogate for wound closure. n=6 biological replicates. (J-L) Lineage-tracing strategy (J), histological analysis of tdtomato+
fibroblasts (red) labelled with Lrig1CreER and Dlk1CreER (K), and quantitation (L) in PW7 wound beds from P2 wounded mice. (K) Dotted lines denote the
epidermal-dermal boundary, arrowheads indicate developing DP and asterisk shows Lrig1CreER-labelled keratinocytes (Page et al., 2013). (L) Percentage
of new HFs with attached tdtomato+ fibroblasts. Eight wound bed sections per mouse; n=4 Lrig1CreER, n=3 DLK1CreER. Nuclei are stained with DAPI (blue
in A,C,D,K). Data shown are means±s.d. ns, not significant; *P<0.05, **P<0.005, ***P<0.0005. DP, dermal papilla; HF, hair follicle; IP, intraperitoneal.
Scale bars: 100 µm in A,D; 50 µm in C,K; 50 mm in E,G.
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(Fig. 1D, Table S1) than in P10 back skin. This indicates that
wound-induced HF regeneration potential is not restricted to one
particular anatomical site. Tail HF formation also appeared to
decline with age (Table S1). There was no correlation between
wound area at PW7 and HF regeneration capacity in either tail or
back skin (Fig. 1E-H). Back skin wound sizes at PW7 were
significantly smaller when mice were wounded in telogen (P21,
P50) than anagen (P2-P10, P28, P36), whereas in tail skin wound
size did not change with age (Fig. 1F,H). Closure rates were similar
in neonatal and adult wounds (Fig. 1I).
To establish the relative contributions of different fibroblast
lineages to new HF formation, we labelled Lrig1+ or Dlk1+ cells
via CreER-mediated recombination with tdtomato at P0,
wounded back skin at P2 and analysed new HF formation at
P9 (Fig. 1J,K). Cells of both the papillary (Lrig1+) and reticular
(Dlk1+) lineages were present in the wound bed (Fig. 1K). The
papillary fibroblast lineage was associated with the DS and DP of
new HFs (eight wound bed sections analysed per mouse; n=4
mice), whereas the reticular lineage only contributed to the inter-
HF dermis (eight wound bed sections analysed per mouse; n=3
mice) (Fig. 1K,L).
We conclude that neonatal skin of different anatomical sites
is able to generate HFs at the site of small, full-thickness
wounds and that papillary fibroblasts contribute to the new HF,
DS and DP, as reported previously (Driskell et al., 2013). HF
neogenesis is more pronounced in back than in tail skin, which
might be due to differences in HF density of unwounded skin, and
declines with age. HF formation is not dependent on the HF stage at
which the wound is made and does not correlate with wound area
at PW7.
Changes in fibroblast gene expression with dermal
maturation and location
To uncover potential explanations for the differences in HF
formation at different ages and body sites, we performed gene
expression profiling of neonatal (P1) back and tail dermis
(GSE83117, Table S2) and compared the results with a published
dataset of back skin dermal fibroblasts isolated from neonatal (P2)
and adult (P50) mice (Collins et al., 2011). We found 705 entities
that were differentially expressed (≥2-fold) between neonatal back
and tail dermis, and 5405 entities that were differentially expressed
in neonatal and adult back skin fibroblasts (Fig. 2A). Only 238
entities overlapped between the two datasets, reflecting genes that
changed with both time and location. Therefore, the majority of
differences in gene expression are between neonatal and adult
dermis rather than between neonatal dermis in different anatomical
locations.
Gene ontology (GO) analysis of entities differentially represented
between neonatal tail and back dermis included the GO terms
‘connective tissue’ and ‘appendage development’, which were more
Fig. 2. Comparative gene expression analysis reveals differences associated with time and body location. (A) Comparison of genes that are differentially
expressed between P1 back and tail dermis (location) and between P2 and P50 dorsal fibroblasts (time). Representative GO term analysis of upregulated entities
is shown. (B) Heatmap depicting the differentially expressedWnt target genes among the four samples analysed. Can., canonical; FC, arbitrary fold change; Inv.,
involved; Neg., negative; Neo., neonatal; Reg., regulation.
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highly represented in the tail. ‘Fat metabolism processes’ was more
highly represented in back dermis, consistent with the lack of
DWAT in tail skin.
GO terms for entities that changed in back skin between P2 and
P50 included ‘cell division’, ‘cell cycle’ and ‘DNA replication’, all
of which were significantly downregulated during postnatal skin
maturation. By contrast, there was a higher representation of entities
associated with immune response, angiogenesis, ECM and wound
healing in adult back fibroblasts. Additionally, many Wnt pathway
components were downregulated with age, whereas there was little
differential expression of Wnt pathway genes between neonatal
back and tail dermis (Fig. 2B).
Taken together, the microarray comparisons of RNA isolated
from the dermis at different times and locations revealed that the
positional identity of fibroblasts (back versus tail) affected only a
small number of genes, whereas postnatal dermal maturation
triggered changes in multiple genes, including the downregulation
of genes associated with cell proliferation and Wnt signalling.
Postnatal dermal expansion occurs with minimal fibroblast
proliferation
To evaluate changes in postnatal dermis that correlate with
loss of HF forming ability, we labelled the dermis of
PDGFRaH2BeGFP mice (with a histone H2B-eGFP reporter
knocked into the Pdgfra locus) for markers that distinguish
different fibroblast subpopulations at P2 (Driskell et al., 2013)
(Fig. 3A,B). Quantitation of total dermal fibroblasts, based on the
expression of nuclear EGFP, showed a striking reduction in
Fig. 3. Changes in fibroblast density, marker expression, proliferation and apoptosis in postnatal back skin. (A-D) Fibroblast density and marker
expression analysis. Immunostaining for Itga6 (A) and CD26, Lrig1, Dlk1 and Sca1 (red) (B) in PDGFRaH2BeGFP (green) skin. White dotted lines (A) mark
dermis layer boundaries. (C) Mean dermal area between adjacent HFs (right y-axis) and total fibroblast density per mm2 of dermis (left y-axis) over time.
(D) Fibroblast density in dermis layers indicated in A. (E,F) Ki67 staining (red) of whole-mounts (E) and quantification (F) of percentage Ki67+ PDGFRaH2BeGFP
cells (green). (G,H) Cleaved caspase 3 (cCasp3) staining (red) of whole-mounts (G) and quantification (H) of percentage cCasp3+ PDGFRaH2BeGFP cells
(green). Note that most apoptotic cells in the skin are observed in the interfollicular epidermis (IFE) and HF keratinocytes (arrowheads in G). Nuclei were labelled
with DAPI (blue in A,B,E,G). Pap, papillary dermis; Ret, reticular dermis; DWAT, dermal white adipose tissue. Data shown are means±s.d. n=3 biological
replicates per time point (C,D,F,H). **P<0.005, ***P<0.0005. Scale bars: 100 µm.
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fibroblast density between P2 and P10, with further reductions at
P21 and P50 (Fig. 3C). By contrast, between P2 and P50 the area
between adjacent HFs increased markedly, reflecting dermal
expansion (Fig. 3C). When we scored cell density separately in
the papillary, reticular and DWAT layers (Fig. 3D), we found that
papillary dermis had the highest cell density at P2 and showed a
marked decrease at P21. However, between P21 and P50 papillary
and reticular cell density both decreased. By contrast, DWAT cell
density marginally increased with age, and at P50 the density in all
three dermal layers was similar (Fig. 3A,D). During skin maturation
there were also major changes in expression of the P2 markers of
papillary (CD26+, Lrig1+) and reticular/DWAT (Dlk1+/−, Sca1+)
dermis, as previously reported (Driskell et al., 2013). CD26 and
Sca1 (also known as Ly6a) expression extended throughout the
dermis with age, whereas Lrig1 and Dlk1 were strongly
downregulated (Fig. 3B).
To investigate whether the dermal changes correlated
with fibroblast proliferation and apoptosis, we stained
PDGFRaH2BeGFP back skin whole-mounts for Ki67 and
cleaved caspase 3 (cCasp3) (Fig. 3E-H). We observed a strong
reduction in Ki67+ fibroblasts between P2 and P10 (Fig. 3E,F), and
proliferation remained low with increasing age. Very few cCasp3+
fibroblasts were detected at any age (Fig. 3G,H), while apoptosis in
the epidermis was HC dependent, as reported previously (Lindner
et al., 1997).
We conclude that during dermal maturation the area between HFs
increases, while fibroblast density decreases. The most pronounced
decrease in cell density is in the papillary layer, coinciding with the
loss of HF neogenesis in wounds. The decrease in dermal cell
density does not correlate with increased apoptosis, and after P2
there is very little fibroblast proliferation, consistent with the
microarray analysis (Fig. 2A).
Clonal analysis of fibroblasts during dermal maturation
To gain more insight into the changes in fibroblast number and
distribution during dermal maturation we first used our experimental
measurements (Fig. 3C, Table S3) to model the number of cell
divisions between P2 and P50 (Fig. 4A). By calculating mouse body
size at each stage and modelling the body as a cylinder, we
calculated that dermal volume increases 13-fold from 0.18 cm3 (P2
mouse) to 2.32 cm3 (average between P50 male and female mice).
Combining this with the fibroblast density measurements (Fig. 3C),
we predicted that on average only 1.3 cell divisions occur in
PDGFRa (Pdgfrα)+ fibroblasts between P2 and P50 (Fig. 4A). This
is consistent with the low number of proliferating cells observed
experimentally (Fig. 3E,F). From here we could further predict that
individual fibroblasts labelled at E12.5 would initially form clones
of increasing cell number, but after P2 clone size would seem to
decrease as clonally related cells became distributed over an
increasing area of dermis.
To test our hypothesis we performed clonal analysis, defining
the maximum diameter occupied by clonally related cells as
260±50 µm, as described previously (Driskell et al., 2013).
Fibroblasts in bi-transgenic PDGFRaCreERt2×CAGCATeGFP
Fig. 4. Estimation of cellular replication during dermal maturation and clonal analysis of PDGFRaCreERt2-positive cells. (A) Predicted number of dermal
fibroblast divisions (trunk skin) during the transition from neonatal (P2) to adult (P50) mouse. Height, length and dermis diameter were measured (n=3 mice per
time point and gender) and the dermis volume was estimated by representing the mouse trunk as a cylinder. Cell densities were obtained from Fig. 3C and the
cell number at P2 (N0) and P50 (N ) were estimated by multiplying cell density and dermis volume. The predicted cell division rate (n=1.3) is calculated by the log2
of the N/N0 ratio. All raw data for the calculations are shown in Table S3. (B-H) Clonal analysis of PDGFRaCreERt2
+ cells. (B) Breeding strategy for E-H.
(C) Labelling strategy for E,F. (D) Labelling strategy for G,H. (E) Immunostaining of GFP+ fibroblasts (green) co-stained for Dlk1 or Itga8 (red) or overlaid with
the brightfield image. (F) Quantitation of GFP+ cells per clone per compartment. n=3 biological replicates per time point. Cells were considered clonally related if
they were contained within a total dermal area of 260 µm diameter (Driskell et al., 2013). (G) Immunostaining of GFP+ fibroblasts. (H) Quantitation of GFP+
fibroblasts in the area between adjacent HFs. n=3 biological replicates per time point. Nuclei were labelled with DAPI (blue in E,G). Data shown are means±s.d.
Scale bars: 1 cm in A; 100 µm in E (middle and right), G; 500 µm in E (left).
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mice were labelled with a low tamoxifen dose, which resulted in 1-2
PDGFRa+ cells being labelled in the dermis between adjacent HFs
(inter-HF dermal area) (Fig. 4B-D). When fibroblasts were labelled
at E12.5 they gave rise to clones of 4-8 cells spanning the papillary
and reticular dermis and DWAT at P2 (Fig. 4E,F). Thereafter, the
number of cells per clone decreased in the papillary and reticular
dermis and DWAT, but not in the DP, consistent with DP cells
forming a condensate (Kaushal et al., 2015; Tobin et al., 2003)
(Fig. 4F). When clonal labelling was performed in bi-transgenic
mice at P0 (Fig. 4D,G), there was no subsequent increase in EGFP+
cells (Fig. 4H), consistent with the very low proliferation rate in
postnatal skin (Collins et al., 2011) (Fig. 3F).
We conclude that, consistent with the postnatal increase in
dermal volume occurring with very little fibroblast proliferation,
clonally related cells become progressively separated from one
another.
Postnatal dermal maturation coincides with a reduction in
dermal β-catenin signalling
In addition to predicting a reduction in fibroblast proliferation
during dermal maturation, the microarray comparison suggested a
significant decrease in Wnt/β-catenin signalling. As a readout of
dermal Wnt signalling we examined the TOPGFP reporter mouse,
in which H2BeGFP is expressed under the control of multiple Lef1/
TCF binding sites (Ferrer-Vaquer et al., 2010) (Fig. 5). As
previously reported, at E12.5 Wnt/β-catenin signalling is highly
active in most fibroblasts (Chen et al., 2012; data not shown).
TOPGFP+ fibroblasts were abundant at P2, but declined
significantly by P21 (Fig. 5A-C). At P2 the number of cells with
detectable nuclear TOPGFP, as evaluated by flow cytometry
(Fig. 5D,E), was 17.1% within the papillary (CD26+ Sca1−)
population, compared with 7.2% in the reticular (Dlk1+ Sca1−)
population and 11.8% in fibroblasts with adipogenic potential
Fig. 5. Dermal Wnt signalling activity. (A,B) Immunostaining for TOPGFP signal (green) and the markers indicated: CD26 (red) and Sca1 (blue) in A; Lef1,
TCF1, TCF4, Dkk1 and cyclin D1 (red) in B. Nuclei were labelled with DAPI (white in A, blue in B). (C) Quantitation of percentage TOPGFP+ dermal fibroblasts
determined from histological sections. n=3 biological replicates per time point. (D,E) Flow cytometry analysis of TOPGFP expression in P2 fibroblast
subpopulations. Gate 1, CD26+ Sca1− (papillary fibroblasts); gate 2, Dlk1+ Sca1− (reticular fibroblasts); gate 3, Dlk1+ Sca1+; gate 4, Dlk1− Sca1+ (cells with
adipogenic potential). C is representative of n=3 biological replicates shown in D. Data shown are means±s.d. *P<0.05, ***P<0.0005. Scale bars: 50 µm.
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(8.3% Dlk1+ Sca1+; 3.5% Dlk1− Sca1+) (Driskell et al., 2013; Festa
et al., 2011). This was confirmed by immunofluorescent staining,
since at P2 the upper dermis (enriched for papillary Lrig1+ CD26+
fibroblasts) contained more TOPGFP+ cells than the lower dermis
(Dlk1+ Sca1+) (Fig. 5A).
In line with the microarray analysis, proteins encoded by Wnt
target genes such as Lef1, Dkk1 and cyclin D1 were highly
expressed in the upper dermis at P2 (Fig. 5B). While most
TOPGFP+ cells in the upper dermis showed high nuclear Lef1
levels, in the lower dermis TCF4 (also known as Tcf7l2) was
nuclear in cells that were TOPGFP+. By contrast, nuclear TCF1
(also known as Tcf7) was mainly confined to the papillary fibroblast
lineage. These observations are consistent with gene expression
profiles of neonatal fibroblasts, showing that papillary fibroblasts
have an active Wnt signalling signature, but also highlight that Wnt
signalling can simultaneously occur in the lower dermis (Driskell
et al., 2013; Mastrogiannaki et al., 2016).
In adult skin there were fewer TOPGFP+ cells throughout the
dermis, with adipocytes and APM cells showing the highest
TOPGFP signal (Fig. 5A-C). The decrease in dermal TOPGFP
activity was associated with a decrease in the expression of all TCFs
as well as all analysed Wnt target genes (Fig. 5B).
We conclude that postnatal dermal maturation is associated with
a reduction in Wnt/β-catenin signalling. Additionally, there is
differential signalling activity in different fibroblast subpopulations.
Wound-induced dermal β-catenin activation in fibroblasts
increases with age
To examine whether the age-associated fibroblast density changes
and Wnt/β-catenin signalling in unwounded skin were mirrored by
changes during wound healing, we investigated β-catenin activity
in wound beds of neonatal and adult TOPGFP mice at PW5, PW7
and PW10. Surprisingly, there was strong dermal Wnt/β-catenin
activation in adult P21 and P50 wound beds, whereas neonatal
P2 wound beds had fewer TOPGFP+ cells at all time points
(Fig. 6A,B). By contrast, the epidermis showed similar TOPGFP
activation in the wound bed regardless of age at all time points,
except for local upregulation in the placodes of new HFs
(Fig. 6A).
During embryogenesis the Wnt signalling inhibitor Dkk1 is
highly expressed by dermal fibroblasts, creating a permissive
environment for HF formation by locally suppressing Wnt/β-
catenin signalling (Andl et al., 2002; Sick et al., 2006). P2 wound
beds had strong Dkk1 expression in the upper dermis, especially
surrounding the developing HF (Fig. 6F). Dkk1 expression was
strongly reduced in adult wound beds (Fig. 6F), correlating with the
increased number of TOPGFP+ cells (Fig. 6A,B).
Although the total dermal cell density in wounds did not change
significantly with age (Fig. 6C,I), the number of cells expressing
papillary (Lrig1) and reticular (Sca1) markers changed as a function
of age at wounding and the number of days post wounding
(Fig. 6D,E) (Driskell et al., 2013). In P50 mice, more Sca1+ cells
were present in the wound bed 7 days after wounding than in P2
mice, while in P2 wounds Lrig1+ cells predominated at PW7,
particularly close to the basement membrane when new HFs form
(Fig. 6A,D,E). In adult wound beds the number of Lrig1+ cells
increased at PW10 when wound-induced HF neogenesis is not
observed (Fig. 6D). Similarly, there were more Itga8+ cells (a
previously described marker of papillary fibroblasts, DP and APM
cells in P2 skin; Driskell et al., 2013) in neonatal than in adult
wound beds at PW7 (Fig. 6G). By contrast, adult wounds contained
a higher proportion of cells that expressed α-smooth muscle actin
(αSma) at PW7 (Fig. 6H), which we have previously shown, by
lineage tracing, to derive from the lower dermal lineage (Driskell
et al., 2013).
Following P2 wounding there were significantly more
proliferating (Ki67+) cells in PW7 wound beds than at P4
(Fig. 6J). However, there was no significant difference in
proliferation in the wound beds of mice wounded at P4 and P50,
even though HF neogenesis declined during that period (Fig. 1B).
Fibroblast density within neonatal and adult wound beds did not
differ significantly at PW7 (Fig. 6I).
We conclude that the loss of HF forming ability correlates with an
increase in dermal Wnt/β-catenin signalling, a decrease in the
proportion of cells expressing papillary markers and an increase in
αSma+ cells in the wound bed at PW7, when new HFs are able to
form. However, wound beds that differ in their ability to support HF
regeneration do not differ in fibroblast proliferation and density.
Promotion of HF formation in adult wounds by inhibition of
Wnt/β-catenin signalling
To determine whether altering dermal Wnt/β-catenin signalling
would affect HF formation in thewound bed, we specifically deleted
or activated β-catenin in fibroblasts by crossing Ctnnb1flox/flox or
Ctnnb1+/flox(ex3) with PDGFRaCreERt2×tdtomato mice and
applying tamoxifen after birth (P0 and P3) (Mastrogiannaki et al.,
2016). Both deletion and activation of β-catenin resulted inmice that
were viable but smaller, with a shorter tail than controls (data not
shown), effects that probably reflect PDGFRaCre activity in tissues
such as the CNS, bone marrow and developing bone (Betsholtz,
1995). Deletion or activation of β-catenin did not alter fibroblast
density in the papillary and reticular layers, nor did it affect the
expression of papillary and reticular markers in unwounded neonatal
and adult dermis (Fig. 7A-D). There was no effect on APM number
or size (data not shown). However, whereas at P10 the DWAT was
normal, by P57 dermal β-catenin stabilisation led to a reduction
in adipocytes and the accumulation of scattered fibrotic patches,
resulting in an increase in DWAT cell density and total dermal
thickness, as previously reported (Mastrogiannaki et al.,
2016; Hamburg-Shields et al., 2015; Hamburg and Atit, 2012)
(Fig. 7A-E). By contrast, in β-catenin-deleted mice dermal thickness
was slightly reduced (Fig. 7E).
To confirm that dermal β-catenin modulation had indeed been
achieved, we examined TOPGFP activity (Fig. 8). As expected,
β-catenin deletion substantially reduced Wnt reporter activity in
adult P21 wound beds (Fig. 8A,B), where Wnt/β-catenin signalling
is high in control mice (Fig. 6A,B). Conversely, β-catenin
stabilisation increased the number of TOPGFP+ cells in neonatal
P8 wounds (Fig. 8D,E), where Wnt/β-catenin signalling is low in
controls (Fig. 6A,B). In addition, we sorted tdtomato+ cells or used
whole-mount tissue for PCR analysis, confirming efficient deletion
of the floxed exons in both Ctnnb1flox/flox and Ctnnb1+/flox(ex3) cells
(Fig. 8C,F); this is comparable to results reported in other skin
studies (see Enshell-Seijffers et al., 2010a).
Next we wounded the skin at P4 (the earliest possible time point
after β-catenin modulation) or P50 (adult) and analysed the wound
bed at PW7 (Fig. 9A). In P4 wounds, dermal β-catenin activation
led to an increase in Sca1+ cells in the wound bed, whereas more
Lrig1+ cells were present after dermal β-catenin deletion at PW7
(Fig. 9B,C). Although proliferation (Ki67+) in adult wound beds
was significantly decreased in β-catenin-deleted dermis and
increased in β-catenin-activated dermis (Fig. 9D) (Beyer et al.,
2012; Chen et al., 2012), dermal cell density was not significantly
affected at PW7 (Fig. 9E). In addition, wound size was slightly
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increased in P50 β-catenin-activated mice (Fig. 9F) and, as
previously shown, β-catenin modulation did not affect wound
closure (Cheon et al., 2006).
Intriguingly, HF formation in the wound bed was significantly
increased (1.52-fold) on dermal deletion of β-catenin (Fig. 9G,H),
whereas β-catenin stabilisation inhibited HF formation by 30% in
P4 wounds (Fig. 9I,J). We occasionally observed enlarged HFs in
the wound bed upon β-catenin stabilisation (Fig. 9I, arrow), as has
been reported when dermal β-catenin is stabilised during
embryonic development (Chen et al., 2012). When β-catenin-
deleted mice were wounded at P50, HF regeneration increased
3.27-fold (Fig. 9H). By contrast, β-catenin stabilisation in
fibroblasts did not affect HF regeneration at P21 or P50
(Fig. 9I,J).
We conclude that, consistent with the observed reduction in
dermal Wnt signalling with age (Fig. 5), β-catenin is not essential
for fibroblasts to contribute to dermal maturation. Wnt/β-catenin
signalling inhibition in fibroblasts promotes HF regeneration during
wound healing, which correlates with a reduction in the number of
cells expressing markers of reticular fibroblasts and an increase in
cells expressing papillary fibroblast markers.
DISCUSSION
It has previously been reported that new HF formation ceases after
E19.5 of mouse development (Colwell et al., 2006; Martin et al.,
2003; Shaw and Martin, 2009). Here we demonstrate that neonatal
mouse skin is capable of forming new HFs during wound healing
and that this ability is largely lost within the first 3 weeks after
birth. The loss of HF ability correlates with a decline in papillary
fibroblast density and dermal β-catenin signalling in undamaged
skin. However, on wounding, dermal β-catenin activity is
upregulated to a greater extent in older than in neonatal wounds
and this is linked to a greater proportion of fibroblasts expressing
reticular markers, consistent with previous lineage-tracing studies
Fig. 6. Analysis of neonatal and adult wound beds. (A,B) TOPGFPexpression in fibroblasts of PW5, PW7 and PW10wound beds ofmicewounded at neonatal
(P2) and adult (P21 and P50) stages.Wound beds were immunostained for GFP (green), Lrig1 (red) and Sca1 (blue) (A). TOPGFPexpression in the boxed areas
is shown at higher magnification beneath. Placodes are marked with asterisks and dotted lines indicate the basement membrane. (B) Quantitation of GFP+ cells
in wound beds at the indicated time points. n=4 biological replicates, except n=3 for P21 and P50 at PW7. (C) Dermal cells per mm2 wound bed area over
time in adult and neonatal wounds. n=4 biological replicates. (D,E) Mean immunofluorescence quantification in the neonatal (P2) and adult (P21, P50) wound
beds over time for Lrig1 (D) and Sca1 (E). n=4 biological replicates per time point. (F) Dkk1 expression (red) in TOPGFP (green) P2 and P50 wound beds at PW7.
(G,H) PW7 wound beds after wounding at the indicated time point, immunostained for Itga8 (green, G) and αSma (green, H). (I) Quantitation of the density of
PDGFRaH2BeGFP-expressing cells in PW7 wound beds wounded at the indicated time points. n=3 biological replicates per time point. (J) Quantitation of Ki67+
cells in the wound beds after wounding at the indicated time points. n=8 (P2), n=6 (P4), n=4 (P21), n=5 (P50) biological replicates. Nuclei were labelled with DAPI
(white in A; blue in F-H). Data shown are means±s.d. ns, not significant; *P<0.05, ***P<0.0005. AU, arbitrary units; IF, immunofluorescence. Scale bars: 100 µm.
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that showed these cells lack HF inducing ability (Driskell et al.,
2013). By ablating β-catenin in PDGFRa+ cells we were able to
partially restore HF formation in wounded older skin. Our results
are consistent with an earlier report showing that during wound
repair β-catenin signalling is strongly upregulated in the fibroblasts
of adult mice (Cheon et al., 2006). It is notable that the loss of hair
forming capacity in adult skin does not reflect a change in the
ability of the epidermis to form new HFs, since ectopic HFs can be
induced in unwounded and wounded skin by epidermal β-catenin
activation (Deschene et al., 2014; Lo Celso et al., 2004; Ito et al.,
2007; Silva-Vargas et al., 2005).
It is interesting to speculate that one reason why P2 skin can
regenerate HFs whereas P21 skin cannot is that from P5 onwards
many of the papillary fibroblasts are recruited to form the APM
and this may render them unable to contribute to restoring the
papillary dermis (Driskell et al., 2013). However, altered dermal
β-catenin activity did not affect the number or size of individual
APM. There is no evidence that existing DP cells contribute
significantly to wound repair in adult skin (Johnston et al., 2013;
Kaushal et al., 2015). Nevertheless, new DP can be induced upon
epidermal β-catenin activation (Silva-Vargas et al., 2005).
Neonatal tail skin was able to form new HFs in wounds and
this is consistent with the lack of differential Wnt gene expression
between tail and back (Fig. 2). We speculate that there are fewer
wound-associated HFs in neonatal tail skin because of the lower
density of HFs in unwounded tail or the lack of papillary
progenitors of the APM.
The importance of Wnt signalling in skin fibroblasts has
been shown in a number of different contexts. In early
embryogenesis, before E16.5, β-catenin expression in fibroblasts
is required for the formation of the dorsal and ventral dermis, while
ectopic β-catenin activation increases fibroblast density and
disturbs epidermal morphogenesis (Atit et al., 2006; Chen et al.,
2012; Ohtola et al., 2008). In late embryonic dermis, when
fibroblast lineages have been established, altered β-catenin activity
in the DP causes defects in HF growth, cycling and pigmentation
but does not cause HF loss (Enshell-Seijffers et al., 2010a,b). By
contrast, β-catenin activation in postnatal dermal fibroblasts causes
fibrosis in the adipocyte layer (Mastrogiannaki et al., 2016;
Hamburg and Atit, 2012; Hamburg-Shields et al., 2015),
supporting our observations in older unwounded skin (Fig. 7B).
This corroborates the idea that β-catenin can be simultaneously
active in different fibroblast lineages performing distinct functions.
Interestingly, during wound repair ectopic β-catenin activation
throughout the skin leads to increased wound size, fibroblast
proliferation and fibrosis, while β-catenin deletion decreases
proliferation and wound size (Fig. 9D,E) (Beyer et al., 2012;
Cheon et al., 2006).
Fig. 7. Effect of postnatal dermal
β-catenin ablation or activation
on skin homeostasis.
(A,B) Immunostaining of Lrig1 (green,
top rows), CD26 (green, bottom rows)
and Sca1 (red) in neonatal (P10) and
adult (P57) whole-mount sections of
wild-type mice (control) or following
β-catenin (Ctnnb1) ablation [Ctnnb1
(KO)] or activation [Ctnnb1(Ex3)], as
shown in Fig. 9A. White dotted lines
indicate dermis layer boundaries.
(C,D) Quantification of cell densities in
the indicated dermis layers in A and B
in neonatal (P10, C) and adult (P57, D)
whole-mount sections. n=6 whole-
mount sections per mouse, n=3
biological replicates per genotype and
time point. (E) Quantification of dermal
thickness at the indicated time points.
n=5 biological replicates per genotype
and time point. Nuclei were labelled
with DAPI (blue in A,B). Data shown
are means±s.d. ns, not significant;
*P<0.05, **P<0.005. Scale bars:
100 µm.
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It is interesting that postnatal mouse growth does not correlate
with an increase in fibroblast proliferation within the dermis
(Collins et al., 2011, 2012), and our clonal analysis is consistent
with a model whereby fibroblasts within a clone become separated
from one another through ECM deposition. Fibroblast β-catenin
activation can stimulate ECM production (Hamburg-Shields et al.,
2015), and although this could play a role in dermal wound repair it
is unlikely to be the major mediator of postnatal dermal expansion,
since signalling is downregulated postnatally.
Weconclude that postnatal dermalmaturation facilitates rapidwound
repair through recruitment of lower dermal fibroblasts but that this
comes at the expense of the ability to regenerate HFs at the wound site.
MATERIALS AND METHODS
Transgenic mice
All animal experiments were subject to local ethical approval and
performed under the terms of a UK government Home Office license. All
mice were outbred on a C57BL6/CBA background and male and female
Fig. 8. TOPGFP activity and β-catenin deletion efficiency in dermal fibroblasts. (A) TOPGFP activity (green) with Lrig1 immunostaining (red) in P21 wounds
at PW7 of wild-type (control) and β-catenin-deleted [Ctnnb1(KO)] mice. (B) Quantitation of GFP+ cells in PW7wound beds. n=6whole-mount sections per mouse;
n=4 control, n=2 Ctnnb1(KO) biological replicates. (C) Schematic representation of the undeleted and deleted β-catenin targeted allele. DNA from sorted
tdtomato-positive (+) and tdtomato-negative (−) cells was tested for β-catenin deletion (primers indicated by red arrows). Ctnnb1(KO) shows a 480 bp band
indicating β-catenin deletion and loss of the 180 bp loxP PCR product, whereas undeleted cells (tdtomato−) generate only the 180 bp loxP PCR product. In
heterozygous mice [Ctnnb1(Het)] the untargeted allele amplifies as a 150 bp band owing to the missing loxP site. Rpl19 PCR was used as loading control.
(D) TOPGFP activity (green) with Lrig1 immunostaining (red) in P8 wounds at PW7 of wild-type (control) and β-catenin-stabilised [Ctnnb1(Ex3)] mice.
(E) Quantitation of GFP+ cells in PW7wound beds. n=6whole-mount sections per mouse; n=4 biological replicates per genotype. (F) Schematic representation of
the wild-type, undeleted and deleted targeted exon 3 allele for β-catenin stabilisation. DNA isolated from whole-mount sections was tested for β-catenin exon 3
deletion (primers indicated by red arrows). Thewild-type allele amplifies as a 900 bp band, the undeleted targeted allele gives no product and the deleted targeted
allele amplifies as a 700 bp band. Note that Ctnnb1(Ex3) transgenic is kept heterozygous, and thus PCR shows efficient recombination. NC, negative control (no
DNA). (A,D) Nuclei were labelled with DAPI (blue) and arrowheads indicate new HFs. Data shown are means±s.d. ***P<0.0005. Scale bars: 100 µm.
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mice were used in experiments that included PDGFRaCreERt2 (Rivers
et al., 2008), Lrig1CreERt2-IRES-GFP (Page et al., 2013), Dlk1CreERt2
(Driskell et al., 2013), ROSAfl-stopfl-tdTomato (Jackson Laboratories,
007905), CAGCATeGFP (Kawamoto et al., 2000), TopH2BeGFP
(Ferrer-Vaquer et al., 2010), PDGFRaH2BeGFP (Hamilton et al.,
2003), β-catenin floxed (Ctnnb1flox/flox) (Huelsken et al., 2001) and
β-catenin exon 3 deletion [Ctnnb1+/flox(ex3)] (Harada et al., 1999) mice.
To perform lineage tracing or modulate β-catenin activity in fibroblasts,
PDGFRaCreERt2 mice were bred to the appropriate floxed mice and
treated with tamoxifen.
Wounding experiments
Analgesic EMLA cream 5% (AstraZeneca) was applied to the skin for
10 min before mice were anaesthetised using isoflurane (Cp-pharma).
A 2 mm diameter punch biopsy (Stiefel) was used to make a full-thickness
wound in the central back skin or tail base at the indicated time points.
If necessary, the hair on the back was clipped prior to wounding. When
neonatal mice (P2-P10) were wounded, all litter pups were wounded and
housed with their mother until weaning age. Wound closure was quantitated
by comparing digital wound bed photos taken at different times after
wounding.
Fig. 9. Effect of β-catenin ablation or activation on HF formation in wound beds. (A) Experimental design. (B,C) Immunostaining analysis (B) and
quantification (C) for Lrig1 (green) and Sca1 (red) in PW7wound beds of wild-typemice (control) or following β-catenin ablation [Ctnnb1(KO)] or activation [Ctnnb1
(Ex3)] wounded at P4. n=3whole-mount sections permouse; n=5 biological replicates per genotype. (D-F) Quantification of Ki67+ cells in thewound bed area (D),
dermal cells in the wound bed (E) and wound bed area (F) at PW7 of wild-type mice or following β-catenin ablation or activation. Mice were wounded at the
indicated time points. (D) n=5 for P50 control, Ctnnb1(KO), n=7 for P4 control, n=4 for P4Ctnnb1(KO), Ctnnb1 (Ex3), P50Ctnnb1(Ex3); (E) n=5; (F) n=6 biological
replicates. (G,I) Immunostaining of newHFs in PW7wound beds of mice following β-catenin ablation (G) or activation (I) in postnatal fibroblasts.Wound beds were
immunostained for Krt14 (red), Itga6 (green) or tdtomato (red) as indicated. White lines demarcate wound edges; arrowheads indicate new HFs and arrow
indicates an enlarged new HF. (H,J) Quantitation of HF formation in wound beds shown in G and I. (H) n=8 for P4 control, P50 Ctnnb1(KO), n=6 for P4 Ctnnb1
(KO), n=9 for P50 control; (J) n=9 for P4 control, n=4 for P4 Ctnnb1(Ex3), P50 control, Ctnnb1(Ex3), n=3 for P21 control, Ctnnb1(Ex3) biological replicates. Nuclei
were labelled with DAPI (blue in B,G,I). Data shown are means±s.d. ns, not significant; *P<0.05, **P<0.005, ***P<0.0005. AU, arbitrary unit; BW, body weight; IF,
immunofluorescence. Scale bars: 100 µm.
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CAGCATeGFP mice were crossed with PDGFRaCreERt2 mice. Cre was
induced at E12.5 by injecting pregnant females with 25 µg tamoxifen/g
body weight, which we have previously shown labels fewer than 1% of all
skin fibroblasts (Driskell et al., 2013). At E14.5 GFP+ cells were analysed in
n=3 horizontal whole-mounts per embryo (n=3 embryos per time point) by
confocal microscopy. All labelled cells within a 260±50 µm radius (Driskell
et al., 2013) were scored as being clonally related. For postnatal clonal
analysis neonatal mice (P0) were injected with 12.5 µg tamoxifen/g body
weight, labelling 1-2 cells per HF region, i.e. the area of dermis between
adjacent HFs, and analysed at different time points. All clones in n=3 whole-
mounts per mouse (n=3 mice per time point) were analysed.
Immunostaining
Immunostaining was performed on 60 µm cryosections stained as horizontal
whole-mounts, as previously described (Driskell et al., 2013, 2011b).
Briefly, skin was fixed in 4% PFA for 15-30 min, washed with PBS and
embedded in OCT (Sakura Finetek). Sections (60 µm) were placed in PBS
to dissolve the OCT. Sections were stained in 300-500 µl PB buffer (PBS
containing 0.5% skimmed milk, 0.25% cold water fish skin gelatin, 0.5%
Triton X-100). Whole-mounts were labelled with primary antibody
overnight at 4°C, washed in PBS for 1 h at room temperature, and with
secondary antibodies containing DAPI (1 µg/ml diluted 1:2000) for 2 h at
room temperature (antibodies are described in Table S4). Whole-mounts
were mounted on coverslips with glycerol and imaged with a Nikon A1
upright confocal using the NIS-Elements software package to stitch multiple
1024×1024 images. Since wounds were only 2 mm in diameter we could
capture the entire width of each wound in one whole-mount (60 µm section)
and, by analysing multiple whole-mounts from each wound, we could
readily quantitate all the HFs per wound.
Flow cytometry
Fibroblasts were isolated as previously described (Jensen et al., 2010).
Briefly, back skin was isolated and incubated in dispase-trypsin solution at
37°C for 1 h. Dermis was separated from the epidermis, transferred to 0.25%
collagenase in FAD medium, minced and incubated at 37°C for 1 h. The
digest was passed through a 70 µm filter before centrifugation. For cell
sorting, cells were washed with PBS and sorted using a BD FACSAria
Fusion. For FACS analysis, fibroblasts were incubated for 1 h with
antibodies (Table S4), washed with PBS and analysed with a BD
FACSCanto TMII. All data analysis was carried out with FlowJo 9.8.5.
Microarrays
Neonatal (P2) and P50 back skin PDGFRaH2BeGFP fibroblast microarrays
were published previously (GEO GSE32966) (Collins et al., 2011). To
generate back and tail dermis microarrays from P1mice (C57BL6/CBA F1),
tail skin was incubated in 5 mMEDTA in PBS at 37°C for 1 h, whereas back
skin was incubated in dispase-trypsin solution at 37°C for 1 h. Tail and back
dermis were separated from the epidermis with forceps, washed once in PBS
and digested as described above. Single-cell suspensions were washed three
times in PBS before cells were lysed in Trizol (Invitrogen) and RNA was
purified using Qiagen RNeasy columns. RNAwas extracted from triplicate
mice. cDNA was amplified from purified RNA and hybridised to
Affymetrix MG430.2A arrays by the Cancer Research UK Patterson
Institute Affymetrix Genechip Microarray Service. Array images were
produced by the Affymetrix PICR 3000 scanner and analysed as CEL files
using GeneSpring 13X (Agilent Technologies). RMA normalisation was
used and the bottom twentieth percentile of genes (i.e. the 20% of genes with
the lowest expression levels) were excluded from subsequent analysis.
Quantitation and statistical analysis
Statistical analysis was performed with GraphPad Prism 6 software. Unless
stated otherwise, statistical significance was determined by unpaired t-test
for biological effects with an assumed normal distribution. For unbiased cell
identification with DAPI, Ki67, TOPH2BeGFP or PDGFRaH2BeGFP
labelling, nuclear staining was quantified using the Spot detector plugin of
Icy software (version 1.6.0.0). To quantify Lrig1+ and Sca1+ cells in the
wound bed, mean fluorescence was determined with Icy software (version
1.6.0.0) and normalised to background.
To quantitate new HFs, at least eight 60 µm sections per wound covering
the entire wound bed were stained with the indicated antibodies and HFs per
wound bed counted. Total and dermal layer fibroblast density was
quantitated in PDGFRaH2BeGFP whole-mount sections by counting
EGFP+ cells in the dermis between adjacent HFs (30 inter-HF regions
scored per biological replicate) and in the wound bed (three wound beds per
biological replicate) at the indicated time points.
PCR analysis
Flow cytometry was used to sort tdtomato+ and tdtomato− cells. DNA was
prepared from sorted cells and whole-mount sections with DNA lysis buffer
(100 mM Tris-Cl pH 8.8, 50 mM NaCl, 5 mM EDTA pH 8.0, 0.2% SDS,
0.2 mg/ml proteinase K), precipitated with isopropanol, washed with 70%
ethanol and resuspended in TE buffer (10 mM Tris-Cl, 1 mM EDTA,
pH 8.0).
For PCR analysis, PCR Mastermix (Promega, M7502) and the primer
pairs listed in Table S5 were used. PCR was performed on a C1000 Touch
thermal cycler (Bio-Rad) with the following cycle conditions: 94°C for
1 min, followed by 32 cycles of 94°C for 30 s, 55°C for 1 min, 72°C for
1 min. PCR products were loaded on a 3% agarose gel and imaged with a
Bio-Rad Gel Doc-XR+ system using Image Lab software (version 5.2).
Calculation of cell division rate
We measured the body length (from between the scapulae to the tail base),
width (at the widest point) and dermis depth (from back skin sections) of
P2 and P50 mice (n=3 biological replicates) (Table S3). We used these
measurements to obtain the approximate body size, represented as a cylinder
(Fig. 4A). The total mouse volume can be approximated by calculating the
cylinder volume V:
V ¼ pr2h; ð1Þ
where the radius r represents half of the body width and h the animal height.
The dermis volume dv corresponds to the difference between the total
volume and the inner volume when the radius is the animal total radius
minus the dermis depth dd:
dv ¼ pr2h pðr  ddÞ2h: ð2Þ
LetN be the number of fibroblasts in P50 occupying dvP50,N0 the number of
fibroblasts in P2 occupying dvP2 and n the predicted number of cell
divisions. If we assume exponential cellular growth then:





The total number of fibroblasts at a certain developmental stage can be
approximated by multiplying the dermis volume dv by the fibroblast density





giving n=1.3128. Based on this result we estimate that dermal fibroblasts
undergo one cell division between P2 and P50.
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